Biological basis of anxiety disorders and serotonergic anxiolytics

Japanese Journal of Neuropsychopharmacology

Volumn 24, Issue 3, 2004, Pages 125-131

  Inoue, Takeshi ^a   Izumi, Takeshi ^a   Li, Xiao Bai ^a   Huang, Ji Zhong ^a   Kitaichi, Yuji ^a   Nakagawa, Shin ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anxiety disorder; Conditioned fear stress; Freezing; Serotonin; SSRI

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CITALOPRAM; FLUVOXAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PROTEIN C FOS; SEROTONIN 1A AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; CONDITIONED REFLEX; DEPRESSION; DRUG MECHANISM; DRUG TARGETING; FEAR; GENE EXPRESSION; GENERALIZED ANXIETY DISORDER; IN VIVO STUDY; LONG TERM POTENTIATION; MENTAL STRESS; MICROINJECTION; NEUROTRANSMISSION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; ONCOGENE C FOS; PANIC; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOLOGY; REVIEW; SEROTONINERGIC TRANSMISSION; SOCIAL PHOBIA; TREATMENT INDICATION;

ANIMALS; ANXIETY DISORDERS; BRAIN; DEPRESSION; FEAR; MICE; NEUROTRANSMITTER AGENTS; PANIC DISORDER; RATS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 3242760037     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Bechara, A., Tranel, D., Damasio, H., Adolphs, R., Rockland, C. and Damasio, A. R. (1995) Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science, 269: 1115-1118.
2. Blanco, C., Antia, S. X. and Liebowitz, M. R. (2002) Pharmacotherapy of social anxiety disorder. Biol Psychiatry, 51: 109-120.
3. Borsini, F., Podhorna, J. and Marazziti, D. (2002) Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology, 163: 121-141.
4. Den Boer, J. A. and Westenberg, H. G. M. (1988) Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: A double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol, 3: 59-74.
5. 1A Receptors in Depression and Anxiety. Raven Press, New York, pp 55-81.
6. Dubovsky, S. L. (1990) Generalized anxiety disorder: New concepts and psychopharmacologic therapies. J Clin Psychiat, 51 (suppl): 3-10.
7. Erikkson, E. and Humble, M. (1990) Serotonin in psychiatric pathophysiology. A review of data from experimental and clinical research. In Pohl, R. and Gershon, S. (Eds) Progress in Basic Clinical Pharmacology, Vol. 3. Karger, Basel, pp 66-119.
8. Fanselow, M. S. (1980) Conditional and unconditional components of post-shock freezing. Pavlov J Biol Sci, 15: 177-182.
9. Fanselow, M. S. (1984) What is conditioned fear? Trends Neurosci, 7: 460-462.
10. Fuller, R. W. (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci, 55: 163-167.
11. Hashimoto, S., Inoue, T. and Koyama, T. (1996) Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology, 123: 182-186.
12. Hashimoto, S., Inoue, T. and Koyama, T. (1999) Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Eur J Pharmacol, 378: 23-30.
13. Inoue, T., Koyama, T. and Yamashita, I. (1993) Effect of conditioned fear stress on serotonin metabolism in the rat brain. Pharmacol Biochem Behav, 44: 371-374.
14. Inoue, T., Tsuchiya, K. and Koyama, T. (1994) Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav, 49: 911-920.
15. Inoue, T., Tsuchiya, K. and Koyama, T. (1996) Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol Biochem Behav, 53: 825-831.
16. Inoue, T., Hashimoto, S., Izumi, T., Maki, Y., Muraki, I., Li, X.-B., Kitaichi, Y., Hashimoto, S. and Koyama, T. (2000) Serotonergic neurotransmission and defensive freezing in the conditioned fear stress paradigm. In Hatano, G., Okada, N. and Tanabe, H. (Eds) Affective Minds. Elsevier Science, Amsterdam, pp 91-100.
17. 1A receptors. Eur J Pharmacol, 260: 243-246.
18. LeDoux, J. E. (2000) The amygdala and emotion: A view through fear. In Aggleton, J. P. (Ed) The Amygdala: A Functional Analysis, 2nd ed. Oxford, Oxford University Press, pp 289-310.
19. Li, X. B., Inoue, T., Hashimoto, S. and Koyama, T. (2001) Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur J Pharmacol, 425: 43-50.
20. Maren, S. (1999) Long-term potentiation in the amygdala: A mechanism for emotional learning and memory. Trends Neurosci, 22: 561-567.
21. Pollack, M. H., Zaninelli, R., Goddard, A., McCafferty, J. P., Bellew, K. M., Burnham, D. B. and Iyengar, M. K. (2001) Paroxetine in the treatment of generalized anxiety disorder: Results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry, 62: 350-357.
22. Shibata, S., Yamashita, K., Yamamoto, E., Ozaki, T. and Ueki, S. (1989) Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test. Psychopharmacology, 98: 38-44.
23. 1A receptor-related anxiolytics. Trends Pharmacol Sci, 8: 432-437.
24. Watson, J. B. and Rayner, R. (1920) Conditioned emotional reactions. J Exp Psychol, 3: 1-14.
25. Wise, C. D., Berger, B. D. and Stein, L. (1972) Benzodiazepines: Anxiety-reducing activity by reduction of serotonin turnover in the brain. Science, 177: 180-183.
26. Yoshioka, M., Matsumoto, M., Togashi, H. and Saito, H. (1995) Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmacol Biochem Behav, 51: 515-519.
27. Zohar, J. and Westenberg, H. G. M. (2000) Anxiety disorders: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand, 101 (Suppl): 39-49.